Assessing the cost-effectiveness of hepatitis C screening strategies in France-Reference-Cited by-同舟云学术

Assessing the cost-effectiveness of hepatitis C screening strategies in France

Published:2018-10 Issue:4 Volume:69 Page:785-792
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Deuffic-Burban Sylvie,Huneau Alexandre,Verleene Adeline,Brouard Cécile,Pillonel Josiane,Le Strat Yann,Cossais Sabrina,Roudot-Thoraval Françoise,Canva Valérie,Mathurin Philippe,Dhumeaux Daniel,Yazdanpanah Yazdan

Funder

ANRS

Publisher

Elsevier BV

Subject

Hepatology

Reference47 articles.

1. Hepatitis B and C in the EU neighbourhood: prevalence, burden of disease and screening policies,2010

2. Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors;Meffre;J Med Virol,2010

3. The undiagnosed chronically-infected HCV population in France. Implications for expanded testing recommendations in 2014;Brouard;PLoS One,2015

4. The impact of the prevention programme of hepatitis C over more than a decade: the French experience;Delarocque-Astagneau;J Viral Hepat,2010

5. Trends of hepatitis C screening in France through Rena-VHC and hepatology reference centres surveillance system, 2000–2007;Brouard;Bull Epidemiol Hebd,2009

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost effectiveness of hepatitis C direct acting agents;Expert Review of Pharmacoeconomics & Outcomes Research;2024-05-03

2. Hepatitis C screening in Lithuania: first-year results and scenarios for achieving WHO elimination targets;BMC Public Health;2024-04-15

3. Universal screening for HCV infection in China: An effectiveness and cost-effectiveness analysis;JHEP Reports;2024-04

4. Personalized care approaches to hepatitis C therapy: recent advances and future directions;Expert Review of Anti-infective Therapy;2024-03-11

5. Universal screening and treatment towards the elimination of chronic hepatitis C in China: an economic evaluation;Public Health;2024-03